Stock listing

OTC:SMDPY Sumitomo Pharma Co.Ltd. Stock

US listing (OTC) of Sumitomo Pharma Co.Ltd. · home listing Tokyo:4506

Follow Sumitomo Pharma Co.Ltd. into a list and get an email when it puts out news.

Share price · OTC:SMDPY

$12.80 USD

Close on Oct 19, 2026

Day range
$12.80 – $12.80 USDOct 19, 2026
Volume
2,038 sharesOct 19, 2026
Sumitomo Pharma Co.Ltd. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
OTC:SMDPY$12.80 USD—2,038$12.80$12.80$12.80—Close on Oct 19, 2026
Dusseldorf:DPM€10.67 EUR-0.446 (-4.0%)—€11.00€11.00€10.67€11.12Close on Oct 30, 2026
Frankfurt:DPM€10.87 EUR+0.114 (+1.1%)—€10.95€10.95€10.87€10.76Close on Oct 30, 2026
Munich:DPM€10.98 EUR+0.50 (+4.8%)—€10.98€10.99€10.98€10.48Close on Oct 27, 2026
Ticker
OTC:SMDPY
Asset type
Stock
Exchange
OTC
Currency
USD

What changed lately

Calls

Replays

  • Sumitomo Pharma (Tokyo:4506) Q1 2026 Earnings Call

    Tue, Aug 04, 2026 · 3:30 AM ET

    Watch Transcript

  • Sumitomo Pharma (Tokyo:4506) Q3 2025 Earnings Call

    Fri, Jan 30, 2026 · 11:00 PM ET

    Watch Transcript

  • Sumitomo Pharma (Tokyo:4506) Q2 2025 Earnings Call

    Fri, Oct 31, 2025

    Watch Transcript

Latest news

Summary of Consolidated Financial Results for the Six Months Ended September 30, 2026

Oct 30, 2026

Supplementary Financial Data (IFRS) for the Six Months Ended September 30, 2026

Oct 30, 2026

Summary of Consolidated Financial Results for the Six Months Ended September 30, 2026 [IFRS]

Oct 30, 2026

Sumitomo Pharma Announces Variances Between H1 FY2026 Financial Forecasts and Actual Results and Revisions to FY2026 Financial Forecasts

Oct 30, 2026

Sumitomo Pharma Announces Revision of Its Year-End Dividend Forecast for the Fiscal Year Ending March 31, 2027

Oct 30, 2026

Presentation Material (Conference on Q2 FY2026 Financial Results

Oct 30, 2026

Notice Concerning Gain on Return of Retirement Benefit Trust (Extraordinary Income) Recorded in the Company’s Non-Consolidated Financial Statements

Aug 28, 2026

Regarding a Report Concerning Sumitomo Pharma (The Company's Views on the GCR August 7 Report)

Aug 11, 2026

Additional Explanation Regarding the Report “Sumitomo Chemical and Sumitomo Pharmaceutical: The 116 billion yen Swiss Shuffle”

Aug 6, 2026

Regarding a Report Concerning Sumitomo Pharma

Aug 4, 2026

All Sumitomo Pharma Co.Ltd. news

Decks

Sumitomo Pharma Co.Ltd. on 6ix

News releases
35 in the last 12 months · 38 in all · newest Oct 30, 2026 · oldest 2025
Calls
6 calls with a replay · 6 with a transcript · latest Aug 4, 2026
Decks
152 decks · latest Oct 30, 2026

Where Sumitomo Pharma Co.Ltd. is listed

ListingExchangeCountryCurrency
Tokyo:4506 住友ファーマ · Home listingTokyoJapanJPY
OTC:DNPUFOTCUnited StatesUSD
gettex:DPMgettexGermanyEUR
OTC:SMDPY · This pageOTCUnited StatesUSD
LS Exchange:858257LS ExchangeGermanyEUR
Lang & Schwarz:858257Lang & SchwarzGermanyEUR
Stuttgart:DPMStuttgartGermanyEUR
Tradegate:DPMTradegateGermanyEUR
Dusseldorf:DPMDusseldorfGermanyEUR
Frankfurt:DPMFrankfurtGermanyEUR
Hamburg:DPMHamburgGermanyEUR
Munich:DPMMunichGermanyEUR

Log in to ask 6ix AI your own questions about Sumitomo Pharma Co.Ltd.